Clinical predictors for surfactant retreatment in preterm infants with respiratory distress syndrome: the results of a pooled analysis
2025

Predictors for Surfactant Retreatments in Preterm Infants

Sample size: 448 publication 10 minutes Evidence: high

Author Information

Author(s): Dani Carlo, Poggi Chiara, Agosti Massimo, Bellettato Massimo, Betta Pasqua, Biban Paolo, Corvaglia Luigi, Falsaperla Raffaele, Forcellini Carlo, Gazzolo Diego, Gitto Eloisa, Gizzi Camilla, Lago Paola, Lista Gianluca, Maffei Gianfranco, Mosca Fabio, Napolitano Marcello, Scarpelli Gianfranco, Sandri Fabrizio, Trevisanuto Daniele, Vento Giovanni, Corsini Iuri, Pratesi Simone, Boni Luca

Primary Institution: Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy

Hypothesis

Can clinical predictors identify the need for multiple doses of surfactant in preterm infants with respiratory distress syndrome?

Conclusion

Gestational age, hypertension in pregnancy, and hemodynamically significant PDA can predict the need for multiple doses of surfactant.

Supporting Evidence

  • 68% of infants were treated with a single dose of surfactant.
  • 32% of infants required multiple doses of surfactant.
  • Infants with higher gestational age had a lower odds of requiring multiple doses.
  • Infants born to mothers with hypertensive disorders had a higher odds of requiring multiple doses.
  • Infants with hemodynamically significant PDA had a higher odds of requiring multiple doses.

Takeaway

Doctors can tell if a preterm baby might need more surfactant medicine based on how early they were born and if their mom had high blood pressure.

Methodology

Data were analyzed from three previous studies on infants born between 25+0 and 31+6 weeks of gestation with RDS who were treated with surfactant.

Limitations

The study is a secondary analysis of data from three previous studies, limiting the evaluation of important variables.

Participant Demographics

Infants born between 25+0 and 31+6 weeks of gestation with respiratory distress syndrome.

Statistical Information

P-Value

P<0.001

Confidence Interval

95% C.l. 0.26–0.79; 95% C.l. 1.49–4.31; 95% C.l. 1.66–4.53

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13052-024-01828-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication